Jagsonpal Financial Statements From 2010 to 2024

Stocks . India . 
Stock . Jagsonpal Pharmaceuticals Limited
JAGSNPHARM   636.65  9.80  1.52%   
Jagsonpal Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Jagsonpal Pharmaceuticals Limited investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Jagsonpal Pharmaceuticals financial statements helps investors assess Jagsonpal Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Jagsonpal Pharmaceuticals' valuation are summarized below:
Gross Profit
1.4 B
Profit Margin
0.1071
Market Capitalization
16.9 B
Enterprise Value Revenue
7.2567
Revenue
2.3 B
We have found eighty-two available fundamental trends for Jagsonpal Pharmaceuticals, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Jagsonpal Pharmaceuticals regular fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year.

Jagsonpal Pharmaceuticals Total Revenue

1.82 Billion

Check Jagsonpal Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jagsonpal Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.6 M, Interest Expense of 7.7 M or Total Revenue of 1.8 B, as well as many indicators such as . Jagsonpal financial statements analysis is a perfect complement when working with Jagsonpal Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Jagsonpal Pharmaceuticals Technical models . Check out the analysis of Jagsonpal Pharmaceuticals Correlation against competitors.

Jagsonpal Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.7 B2.2 B1.6 B
Slightly volatile
Short and Long Term Debt Total165.5 M89.4 M194.3 M
Slightly volatile
Total Current Liabilities361.4 M191.3 M372.3 M
Slightly volatile
Total Stockholder Equity1.2 B1.9 B1.1 B
Slightly volatile
Property Plant And Equipment Net88.4 M93 M339.2 M
Slightly volatile
Retained Earnings1.1 B1 B547.5 M
Slightly volatile
Cash199.6 M127.6 M205.6 M
Slightly volatile
Non Current Assets Total169.3 M178.2 M456.2 M
Slightly volatile
Cash And Short Term Investments1.6 B1.5 B472.1 M
Slightly volatile
Net Receivables104 M109.5 M294.7 M
Slightly volatile
Common Stock Shares Outstanding28.8 M26.6 M26.4 M
Slightly volatile
Liabilities And Stockholders Equity1.7 B2.2 B1.6 B
Slightly volatile
Non Current Liabilities Total87.4 M105.5 M72.4 M
Slightly volatile
Inventory247.3 M150 M322.1 M
Slightly volatile
Other Current Assets381.4 M363.2 M105.7 M
Slightly volatile
Other Stockholder Equity105.6 M111.2 M236.1 M
Very volatile
Total Liabilities350.2 M296.8 M438.1 M
Slightly volatile
Total Current Assets1.1 B2 B1.1 B
Slightly volatile
Short Term Debt13.1 M13.8 M164.2 M
Slightly volatile
Common Stock144.2 M132.2 M131.9 M
Slightly volatile
Accounts Payable96 M76 M95.9 M
Slightly volatile
Other Liabilities26 M29.1 M33.5 M
Slightly volatile
Net Tangible Assets1.2 B1.8 B1.2 B
Slightly volatile
Other Assets22.2 M23.4 M82 M
Very volatile
Long Term Investments4 K4.5 K4.9 K
Slightly volatile
Property Plant Equipment258.8 M218.5 M365 M
Slightly volatile
Intangible Assets17.6 M27 M12.1 M
Slightly volatile
Short Term Investments4.5 M4.7 M163.8 M
Pretty Stable
Cash And Equivalents242 M127.1 M207.5 M
Very volatile
Deferred Long Term Liabilities24.6 M27 M22.1 M
Slightly volatile
Net Invested Capital1.5 B1.9 B1.2 B
Slightly volatile
Net Working Capital1.1 B1.8 B826 M
Slightly volatile
Capital Stock144.3 M132.2 M132 M
Slightly volatile
Property Plant And Equipment Gross88.4 M93 M490 M
Slightly volatile
Capital Surpluse4.8 M5.4 M5.9 M
Slightly volatile

Jagsonpal Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization14.6 M16.6 M17.9 M
Slightly volatile
Interest Expense7.7 M8.1 M24.9 M
Slightly volatile
Total Revenue1.8 B2.1 B1.7 B
Slightly volatile
Gross Profit941.8 M652.6 M900.3 M
Slightly volatile
Other Operating Expenses1.7 B1.9 B1.6 B
Slightly volatile
Cost Of Revenue876.7 M1.4 B803.5 M
Slightly volatile
Total Operating Expenses809.7 M438.6 M782.7 M
Slightly volatile
Selling General Administrative72.9 M38 M77.9 M
Very volatile
Selling And Marketing Expenses136.6 M163.4 M111.8 M
Slightly volatile
Research Development3.2 M3.1 M4.2 M
Slightly volatile
Interest Income3.5 M3.7 M21 M
Slightly volatile
Reconciled Depreciation13.7 M16.6 M11.7 M
Slightly volatile

Jagsonpal Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow179.7 M110.5 M196.4 M
Slightly volatile
Depreciation15 M16.6 M18.5 M
Slightly volatile
Capital Expenditures2.4 M2.5 M20.5 M
Slightly volatile
End Period Cash Flow184.2 M127.6 M201.6 M
Slightly volatile
Other Cashflows From Investing Activities77.4 M73.7 M19.4 M
Slightly volatile
Stock Based Compensation113.1 M133.1 M92.4 M
Slightly volatile

Jagsonpal Fundamental Market Drivers

Cash And Short Term Investments1.5 B

About Jagsonpal Pharmaceuticals Financial Statements

Investors use fundamental indicators, such as Jagsonpal Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Jagsonpal Pharmaceuticals' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue12.9 M12.3 M
Total Revenue2.1 B1.8 B
Cost Of Revenue1.4 B876.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Other Information on Investing in Jagsonpal Stock

Jagsonpal Pharmaceuticals financial ratios help investors to determine whether Jagsonpal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jagsonpal with respect to the benefits of owning Jagsonpal Pharmaceuticals security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY